Statements (45)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
chronic viral infection |
| gptkbp:affects |
liver
|
| gptkbp:canBeAsymptomatic |
true
|
| gptkbp:canBeCured |
true
|
| gptkbp:cause |
cirrhosis
hepatocellular carcinoma extrahepatic manifestations |
| gptkbp:causedBy |
gptkb:Hepatitis_C_virus
|
| gptkbp:complication |
gptkb:hepatic_encephalopathy
liver failure portal hypertension |
| gptkbp:cureRateWithDAA |
over 95%
|
| gptkbp:diagnosedBy |
HCV RNA test
HCV antibody test |
| gptkbp:extrahepaticManifestation |
leukemia
nephrotic syndrome cryoglobulinemia |
| gptkbp:firstDescribed |
1989
|
| https://www.w3.org/2000/01/rdf-schema#label |
chronic Hepatitis C
|
| gptkbp:ICD-10_code |
B18.2
|
| gptkbp:noVaccine |
true
|
| gptkbp:prevalence |
over 70 million people worldwide
|
| gptkbp:prevention |
screening blood products
avoid sharing needles |
| gptkbp:progression |
may take decades
|
| gptkbp:riskFactor |
HIV infection
hemodialysis tattooing with unsterile equipment injection drug use |
| gptkbp:screeningRecommendedFor |
high-risk populations
people born 1945-1965 (US) |
| gptkbp:symptom |
nausea
abdominal pain fatigue jaundice joint pain |
| gptkbp:transmittedBy |
blood-to-blood contact
sharing needles blood transfusion (before 1992) |
| gptkbp:treatment |
direct-acting antivirals
interferon (historically) ribavirin (historically) |
| gptkbp:bfsParent |
gptkb:Hepatitis_C
|
| gptkbp:bfsLayer |
5
|